Post-Exposure Prophylaxis

Preventive medical treatment started after exposure to a pathogen to prevent infection or disease.

What is Post-Exposure Prophylaxis?

Post-exposure prophylaxis (PEP) refers to the use of medications, vaccines, or other treatments after a person has been exposed to an infectious disease but before they develop symptoms to prevent infection or reduce disease severity. The word “prophylaxis” means prevention, and PEP is a critical tool when time is of the essence. It is the public health equivalent of a fire extinguisher: used to extinguish a spark before it turns into a big fire.

Depending on the disease, PEP might involve a single dose of vaccine, a short course of antiviral or antibiotic medication, injection with special antibodies, or a combination of these.

PEP is one of the most powerful and targeted interventions in infectious disease control. It is especially valuable for diseases with a known incubation period and for which early treatment or vaccination can block infection. PEP is also essential for protecting people who may not have been previously vaccinated or immune, e.g., infants, healthcare workers, or people with certain medical conditions.

How Post-Exposure Prophylaxis Works

Effective use of PEP requires rapid identification of exposed individuals, quick access to medication or vaccines, and clear communication from healthcare providers.

Common components of PEP

• Vaccination (e.g., measles, hepatitis B, rabies)
• Antiviral medications (e.g., HIV, influenza)
• Antibiotics (e.g., meningococcal disease, anthrax)
• Immune globulin (pre-formed antibodies for immediate protection)
• Combination of treatments (e.g., rabies PEP uses vaccine and immune globulin)
• Wound care or cleansing (especially for rabies or tetanus exposures)

Diseases commonly managed with PEP

• HIV
• Rabies
• Hepatitis B
• Measles
• Meningococcal disease

PEP is a cornerstone of public health strategies for outbreak control, healthcare worker protection, and exposure management.

Example: Post-Exposure Prophylaxis for HIV and Measles

• HIV PEP: A 28-day course of antiretroviral medications started within 72 hours of a high-risk exposure can dramatically reduce the risk of infection.
• Measles PEP: MMR vaccine given within 72 hours of exposure, or immune globulin given within 6 days, can prevent or lessen illness in non-immune individuals.
• Rabies PEP: Requires wound cleansing, rabies immune globulin, and a series of rabies vaccine doses to prevent the disease, which is almost always fatal once symptoms appear.

Key Considerations for Effective PEP Programs

• Rapid identification of exposed individuals
• Ensuring access to PEP medications and vaccines
• Clear guidelines for healthcare providers
• Public education about when and how to seek PEP
• Monitoring and follow-up of individuals receiving PEP